Adult acute myeloid leukemia 
Age: ≥18 and ≤ 60 
Clinical condition of the patient allows to carry out induction therapy: ECOG performance status: ≤ 2 and the Hematopoietic Cell Transplant-Co-morbidity Index (HCT-I): ≤3 
Informed consent to participate in the study (ICF signed) 
The second early induction start criteria is in addition to the listed above, the percentage of the blasts on the level >10% on 7th day. 

NCT02072811_inc_T1
Condition
Adult acute myeloid leukemia
NCT02072811_inc_T2
Person
Age
NCT02072811_inc_T3
Value
≥18 and ≤ 60
NCT02072811_inc_T4
Measurement
ECOG performance status
NCT02072811_inc_T5
Value
≤ 2
NCT02072811_inc_T6
Measurement
Hematopoietic Cell Transplant-Co-morbidity Index (HCT-I)
NCT02072811_inc_T7
Value
≤3
NCT02072811_inc_T9
Measurement
percentage of the blasts
NCT02072811_inc_T10
Value
>10%
NCT02072811_inc_T11
Temporal
on 7th day